Quality of life in patients with urticaria and angioedema: Assessing burden of disease

Allergy and Asthma Proceedings

Volumn 35, Issue 1, 2014, Pages 4-9

  Weldon, David ^a  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOEDEMA QUALITY OF LIFE QUESTIONNAIRE; ANGIONEUROTIC EDEMA; ARTICLE; CHRONIC URTICARIA AND QUALITY OF LIFE QUESTIONNAIRE; CLINICAL PRACTICE; DERMATOLOGY LIFE QUALITY INDEX; HEALTH SURVEY; HUMAN; HUMAN RELATION; PERSONAL APPEARANCE; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SLEEP; URTICARIA; URTICARIA ACTIVITY SCORE;

ANALYSIS OF VARIANCE; ANGIOEDEMA; HEALTH SURVEYS; HUMANS; PATIENT CARE MANAGEMENT; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; URTICARIA;

EID: 84893351520     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2014.35.3713     Document Type: Article

References (20)

1. Weldon D. Quality of life in patients with urticaria. Allergy Asthma Proc 27:96-99, 2006.
2. Baiardini I, Giardini A, Pasquali M, et al. Quality of life and patients̀ satisfaction in chronic urticaria and respiratory allergy. Allergy 58:621-623, 2003.
3. Jáuregui I, Bartra J, del Cuvillo A, et al. Bilastine and quality of life. J Investig Allergol Clin Immunol 21:16 -23, 2011.
4. Finlay AY, and Khan GK. Dermatology Life Quality Index (DLQI)-A simple practical measure for routine clinical use. Clin Exp Dermatol 19:210-216, 1994.
5. Rogers A, DeLong LK, and Chen SC. Clinical meaning in skinspecific quality of life instruments: A comparison of the dermatology life quality index and skindex banding systems. Dermatol Clin 30:333-342, 2012.
6. Poon E, Seed PT, Greaves MW, and Kobza-Black A. The extent and nature of disability in different urticaria conditions. Br J Dermatol 140:667-671, 1999.
7. Lennox RD, and Leahy MJ. Validation of the dermatology life quality index as an outcome measure for urticaria-related quality of life. Ann Allergy Asthma Immunol 93:142-146, 2004.
8. Baiardini I, Pasquali M, Braido F, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: Chronic urticaria quality of life questionnaire (CU-QoL). Allergy 60:1073-1078, 2005.
9. Weller K, Groffik A, Magerl M, et al. Development and construct validation of the angioedema quality of life questionnaire. Allergy 67:1289 -1298, 2012.
10. Kocaturk E, Weller K, Martus P, et al. Turkish version of the chronic urticaria quality of life questionnaire: Cultural adaptation, assessment of reliability and validity. Acta Derm Venerol 92:419-425, 2012.
11. Delong LK, Culler SD, Saini SS, et al. Annual direct and indirect health care costs of chroinic idiopathic urticaria: A cost analysis of 50 nonimmunosuppressed patients. Arch Dermatol 144:35-39, 2008.
12. Maurer M, Weller K, Bindslev-Jensen C, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report. Allergy 66:317-330, 2011.
13. Yun J, Katelaris CH, Weerasinghe A, et al. Impact of chronic urticaria on the quality of life in Australian and Sri Lankan populations. Asia Pac Allergy 1:25-29, 2011.
14. Ue AP, Souza PK, Rotta O, et al. Quality of life assessment in patients with chronic urticaria. An Bras Dermatol 86:897-904, 2011.
15. Silvares MR, Fortes MR, and Miot HA. Quality of life in chronic urticaria: A survey at a public university outpatient clinic, Botucatu (Brazil). Rev Assoc Med Bras 57:577-582, 2011.
16. Mlynek A, Zalewska-Janowska A, Martus P, et al. How to assess disease activity in patients with chronic urticaria? Allergy 63:777-780, 2008.
17. Kocaturk E, Kavala M, Kural E, et al. Autologous serum skin test vs autologous plasma skin test in patients with chronic urticaria: Evaluation of reproducibility, sensitivity and specificity and relationship with disease activity, quality of life and anti-thyroid antibodies. Eur J Dermatol 21:339 -343, 2011.
18. Weller K, Church MK, Kalogeromitros D, et al. Chronic spontaneous urticaria: How to assess quality of life in patients receiving treatment. Arch Dermatol 147:1221-1223, 2011.
19. Nam YH, Kim JH, Jin HJ, et al. Effects of omalizumab treatment in patients with refractory chronic urticaria. Allergy Asthma Immunol Res 4:357-361, 2012.
20. Kaplan A, Ledford D, Ashby M, et al. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol 132:101-109, 2013.